Oral Insulin: Steps on the Yellow Brick Road


By: Linda Watts

Cortecs International, an Anglo-Australian biotechnology group, recently announced a breakthrough in the search for an oral version of insulin. Cortecs has produced a capsule containing insulin that is able to get to the liver and reduce blood sugar levels. The capsule overcomes the long-standing problem of capsule destruction by the digestive system.

Cortecs’ president Michael Flynn warned that while the new discovery is promising and exciting, people shouldn’t think that the problem is completely solved.

“I don’t want the message to get out that you can throw your syringes away next week,” says Flynn.

As well as dispensing with painful daily injections for some diabetics, oral delivery of insulin could allow the liver’s protective mechanisms to control BGs naturally. This would avoid dramatic surges in insulin levels.

While Cortecs’ discovery offers hope, the capsules still have a way to go in experimental trials. It could be several years before a capsule version of insulin appears on the market. Experiments have focused on type 2 diabetics, but next year capsule trials are scheduled for type 1 subjects.



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.